Patent application number | Description | Published |
20100157741 | ACOUSTIC ISOLATOR - An acoustic isolator for use with tubular assemblies such as drillpipe or production tubing comprising an acoustic wave transmitter, the acoustic isolator comprising, in series connection, an odd integer λ/4 multiple tuning bar of first acoustic impedance adjacent the acoustic wave transmitter, an odd integer λ/4 multiple reflector tube of second acoustic impedance, and a snubber of third acoustic impedance, wherein there is an acoustic impedance mismatch between the odd integer λ/4 multiple tuning bar and the odd integer λ/4 multiple reflector tube and an acoustic impedance mismatch between the odd integer λ/4 multiple reflector tube and snubber, such that a ‘down’ wave propagated toward the isolator is reflected back substantially in phase with an ‘up’ wave propagated from the acoustic wave source away from the isolator. Furthermore, the acoustic isolator is similarly effective in reflecting ‘up’ propagating waves originating from below the isolator, hence further protecting the acoustic wave source from possible deleterious interference. | 06-24-2010 |
20100195441 | PARALLEL-PATH ACOUSTIC TELEMETRY ISOLATION SYSTEM AND METHOD - An acoustic telemetry isolation system and method for use with tubular assemblies such as drillpipe and production tubing includes an acoustic wave transmitter and an acoustic isolator. A “down” wave propagated toward the isolator is reflected back substantially in phase with an “up” wave propagated from the acoustic wave source away from the isolator. Furthermore, the acoustic isolator is similarly effective in reflecting “up” propagating waves originating from below the isolator, hence further protecting the acoustic wave source from possible deleterious interference. The construction of the isolator utilizes a specified combination of waves traveling in parallel in materials whose properties aid the beneficial combination of reflected and transmitted waves. The design of the isolator is to generally provide a bandstop filter function, thereby aiding the frequency isolation of an acoustic transmitter over a passband that may be constrained by the geometry of drill pipe or components of production tubing. It causes substantially all of the emitted wave energy to travel in a chosen direction along the drill pipe, thus aiding the efficiency of acoustic telemetry in the pipe. | 08-05-2010 |
20100208552 | ACOUSTIC TELEMETRY STACKED-RING WAVE DELAY ISOLATOR SYSTEM AND METHOD - A stacked-ring, slow-wave acoustic telemetry isolation system and method for use with tubular assemblies such as drillpipe or production tubing comprising an acoustic wave transmitter, the acoustic isolator behaving such that a “down” wave propagated toward the isolator is reflected back substantially in phase with an “up” wave propagated from the acoustic wave source away from the isolator. The acoustic isolator is similarly effective in reflecting “up” propagating waves originating from below the isolator, hence further protecting the acoustic wave source from possible deleterious interference. It causes substantially all of the emitted wave energy to travel in a chosen direction along the drill pipe, thus aiding the efficiency of acoustic telemetry said pipe. | 08-19-2010 |
20110163889 | TELEMETRY WAVE DETECTION APPARATUS AND METHOD - Non-contacting means of measuring the material velocities of harmonic acoustic telemetry waves travelling along the wall of drillpipe, production tubing or coiled tubing are disclosed. Also disclosed are contacting means, enabling measurement of accelerations or material velocities associated with acoustic telemetry waves travelling along the wall of the tubing, utilizing as a detector either a wireless accelerometer system or an optical means, or both; these may also be applied to mud pulse telemetry, wherein the telemetry waves are carried via the drilling fluid, causing strain in the pipe wall that in turn causes wall deformation that can be directly or indirectly assessed by optical means. | 07-07-2011 |
20150192010 | ACOUSTIC TELEMETRY STACKED-RING WAVE DELAY ISOLATOR SYSTEM AND METHOD - A stacked-ring, slow-wave acoustic telemetry isolation system and method for use with tubular assemblies such as drillpipe or production tubing comprising an acoustic wave transmitter, the acoustic isolator behaving such that a “down” wave propagated toward the isolator is reflected back substantially in phase with an “up” wave propagated from the acoustic wave source away from the isolator. The acoustic isolator is similarly effective in reflecting “up” propagating waves originating from below the isolator, hence further protecting the acoustic wave source from possible deleterious interference. It causes substantially all of the emitted wave energy to travel in a chosen direction along the drill pipe, thus aiding the efficiency of acoustic telemetry said pipe. | 07-09-2015 |
Patent application number | Description | Published |
20080261266 | METHODS AND COMPOSITIONS FOR A MICROEMULSION-BASED TISSUE TREATMENT - The invention is directed to methods and compositions for deparaffinizing paraffin-embedded biological samples for subsequent tissue staining. The compositions are microemulsions that may include water/oil/surfactant microemulsions, and optionally a cosurfactant. The microemulsions enable deparaffinization without the use of xylene or toluene, and also enable solvent exchange without the use of intermediary alcohol dehydration or alcohol rehydration compositions. | 10-23-2008 |
20080287633 | Hydrogel Materials - The present invention relates to biocompatible crosslinked biomaterials made from polycondensation polymerization reactions involving polynucleophilic-polyelectrophilic precursors that address the limitations of steric hindrance, viscosity, and diffusion currently reducing gelation rates and curing thoroughness of the biomaterials. A cross-linking scheme is utilized in the invention that permits rapid gelation and thorough curing of the biomaterial. The biomaterial is made by polycondensation polymerization of polynucleophilic-polyelectrophilic precursors to form a water-soluble polymer crosslinked with a water-soluble crosslinker having at most one core cyclic structure. | 11-20-2008 |
20090202611 | COMPOSITE SELF-COHERED WEB MATERIALS - The present invention is directed to implantable bioabsorbable non-woven self-cohered web materials having a high degree of porosity. The web materials are very supple and soft, while exhibiting proportionally increased mechanical strength in one or more directions. The web materials often possess a high degree of loft. The web materials can be formed into a variety of shapes and forms suitable for use as implantable medical devices or components thereof. | 08-13-2009 |
20100233266 | ARTICLES AND METHODS OF TREATING VASCULAR CONDITIONS - The present invention relates to articles and methods of treating vascular conditions with a thixotropic, turbid, bioactive agent-containing gel material capable of being essentially removed from an implantation site upon re-establishment of fluid flow at the implantation site. | 09-16-2010 |
20110039960 | Expandable Functional TFE Copolymer Fine Powder, the Expanded Functional Products Obtained Therefrom and Reaction of the Expanded Products - A functional TFE copolymer fine powder is described, wherein the TFE copolymer is a polymer of TFE and at least one functional comonomer, and wherein the TFE copolymer has functional groups that are pendant to the polymer chain. The functional TFE copolymer fine powder resin is paste extrudable and expandable. Methods for making the functional TFE copolymer are also described. The expanded functional TFE copolymer material may be post-reacted after expansion. | 02-17-2011 |
20110064781 | NOVEL HEPARIN ENTITIES AND METHODS OF USE - The present invention relates to immobilized biologically active entities that retain a significant biological activity following manipulation. The invention also comprises a medical substrate comprising a heparin entity bound onto a substrate via at least one heparin molecule, wherein said bound heparin entity is heparinase-1 sensitive. | 03-17-2011 |
20110065085 | NOVEL HEPARIN ENTITIES AND METHODS OF USE - The present invention relates to immobilized biologically active entities that retain a significant biological activity following manipulation. The invention also comprises a medical substrate comprising a heparin entity bound onto a substrate via at least one heparin molecule, wherein said bound heparin entity is heparinase-1 sensitive. | 03-17-2011 |
20120035283 | Expandable Functional TFE Copolymer Fine Powder, the Expanded Functional Products Obtained Therefrom and Reaction of the Expanded Products - A functional TFE copolymer fine powder is described, wherein the TFE copolymer is a polymer of TFE and at least one functional comonomer, and wherein the TFE copolymer has functional groups that are pendant to the polymer chain. The functional TFE copolymer fine powder resin is paste extrudable and expandable. Methods for making the functional TFE copolymer are also described. The expanded functional TFE copolymer material may be post-reacted after expansion. | 02-09-2012 |
20130029376 | METHODS AND COMPOSITIONS FOR A MICROEMULSION-BASED TISSUE TREATMENT - The invention is directed to methods and compositions for deparaffinizing paraffin-embedded biological samples for subsequent tissue staining The compositions are microemulsions that may include water/oil/surfactant microemulsions, and optionally a cosurfactant. The microemulsions enable deparaffinization without the use of xylene or toluene, and also enable solvent exchange without the use of intermediary alcohol dehydration or alcohol rehydration compositions. | 01-31-2013 |
20130084460 | Expandable Functional TFE Copolymer Fine Powder, Expanded Products and Reacted Products Therefrom - A functional TFE copolymer fine powder is described, wherein the TFE copolymer is a polymer of TFE and at least one functional comonomer, and wherein the TFE copolymer has functional groups that are pendant to the polymer chain. The functional TFE copolymer fine powder resin is paste extrudable and expandable. Methods for making the functional TFE copolymer are also described. The expanded functional TFE copolymer material may be post-reacted after expansion. | 04-04-2013 |
20130203874 | Expandable Functional TFE Copolymer Fine Powder, Expanded Products and Reacted Products Therefrom - A functional TFE copolymer fine powder is described, wherein the TFE copolymer is a polymer of TFE and at least one functional comonomer, and wherein the TFE copolymer has functional groups that are pendant to the polymer chain. The functional TFE copolymer fine powder resin is paste extrudable and expandable. Methods for making the functional TFE copolymer are also described. The expanded functional TFE copolymer material may be post-reacted after expansion. | 08-08-2013 |
20130253426 | ELUTING MEDICAL DEVICES - The invention is directed to eluting medical devices that enable consistent “on-demand” delivery of therapeutic agents to a vessel. The medical device of the current invention comprises an expandable member, a hydrophilic coating comprising at least one therapeutic agent about the expandable member or structural layer and an outer sheath with a variably permeable microstructure. The design and methods disclosed herein ensures that therapeutic agent delivery occurs essentially only during expansion of the expandable member, minimizing coating and/or therapeutic agent loss to the bloodstream and providing controlled delivery to the treatment site. | 09-26-2013 |
20130309718 | METHODS AND COMPOSITIONS FOR A MICROEMULSION-BASED TISSUE TREATMENT - The invention is directed to methods and compositions for deparaffinizing paraffin-embedded biological samples for subsequent tissue staining. The compositions are microemulsions that may include water/oil/surfactant microemulsions, and optionally a cosurfactant. The microemulsions enable deparaffinization without the use of xylene or toluene, and also enable solvent exchange without the use of intermediary alcohol dehydration or alcohol rehydration compositions. | 11-21-2013 |
20140005286 | Expandable Functional TFE Copolymer Fine Powder, Expanded Products and Reacted Products Therefrom | 01-02-2014 |
20140018457 | Expandable Functional TFE Copolymer Fine Powder, Expanded Products and Reacted Products Therefrom - A functional TFE copolymer fine powder is described, wherein the TFE copolymer is a polymer of TFE and at least one functional comonomer, and wherein the TFE copolymer has functional groups that are pendant to the polymer chain. The functional TFE copolymer fine powder resin is paste extrudable and expandable. Methods for making the functional TFE copolymer are also described. The expanded functional TFE copolymer material may be post-reacted after expansion. | 01-16-2014 |
20140072514 | POLYTETRAFLUOROETHYLENE CO-POLYMER EMULSIONS - The present disclosure is directed to a class of fluorinated copolymers, such as PTFE copolymers, that can be dissolved in low toxicity solvents, such as Class III Solvents, and that enable the creation of stable water-in-solvent emulsions comprising the fluorinated copolymers dissolved in a low toxicity solvents and a hydrophilic agent (e.g., a therapeutic agent) dissolved in an aqueous solvent, such as water or saline. | 03-13-2014 |
20140072518 | POLYTETRAFLUOROETHYLENE CO-POLYMER EMULSIONS - The present disclosure is directed to a class of fluorinated copolymers, such as a PTFE copolymers, that can be dissolved in low toxicity solvents, such as Class III Solvents, and that enable the creation of stable water-in-solvent emulsions comprising the fluorinated copolymers dissolved in a low toxicity solvents and a hydrophilic agent (e.g., a therapeutic agent) dissolved in an aqueous solvent, such as water or saline. | 03-13-2014 |
20140128544 | Novel Heparin Entities and Methods of Use - The present invention relates to immobilized biologically active entities that retain a significant biological activity following manipulation. The invention also comprises a medical substrate comprising a heparin entity bound onto a substrate via at least one heparin molecule, wherein said bound heparin entity is heparinase-1 sensitive. | 05-08-2014 |
20140271774 | Coating For A Surface - Coatings for a surface, especially a priming coating, of the present invention have been found to be durable, resistant to oxidative degradation, erosion and depolymerisation, stable to sterilization and low particulating, and are easily applied to the required surface of a substrate in a surface-independent manner. Such coatings, when used as priming coatings to be coated with a subsequent coating, in at least some embodiments, form exterior coatings which are also highly durable and are stable to sterilisation and aging. | 09-18-2014 |
20140271775 | POROUS COMPOSITES WITH HIGH-ASPECT RATIO CRYSTALS - The present disclosure is directed toward composite materials comprising high aspect ratio habits of drug crystals which can be partially or fully extending into a substrate, and additionally, can be projecting from a substrate at an angle of about 20° to about 90°. The present disclosure is directed toward medical devices, such as medical balloons, comprising said composite and methods of using and making the same. The described composite can be used for the local treatment of vascular disease. The present disclosure is also directed toward paclitaxel crystals with a hollow acicular habit. | 09-18-2014 |
20140364404 | ARTICLES AND METHODS OF TREATING VASCULAR CONDITIONS - The present invention relates to articles and methods of treating vascular conditions with a thixotropic, turbid, bioactive agent-containing gel material capable of being essentially removed from an implantation site upon re-establishment of fluid flow at the implantation site. | 12-11-2014 |
20150258251 | DRUG COMPOSITION AND COATING - According to the invention there is provided inter alia a medical device for delivering a therapeutic agent to a tissue, the device having a solid surfactant-free particulate coating layer applied to a surface of the device, the coating layer comprising a therapeutic agent and at least one non-polymeric organic additive which is hydrolytically stable; wherein at least a proportion of the particulate coating layer comprising the therapeutic agent and the at least one organic additive melts as a single phase at a lower temperature than the melting point of the therapeutic agent and the at least one organic additive when in pure form; wherein the therapeutic agent is paclitaxel; and wherein the therapeutic agent, when formulated in the coating layer, is stable to sterilization. | 09-17-2015 |